Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGCG | Q16739 | 20/20 | 0.67 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19354950 | 1.00 | UGCG (0.67) | UGCGHTR1APTGS1OPRM1 | |
| SCHEMBL19354949 | 0.88 | UGCG (0.55) | UGCGHTR1APTGS1OPRM1 | |
| SCHEMBL13569487 | 0.88 | UGCG (0.67) | UGCG | |
| SCHEMBL13417389 | 0.88 | UGCG (0.67) | UGCG | |
| SCHEMBL12091640 | 0.88 | UGCG (0.67) | UGCG | |
| SCHEMBL13057148 | 0.87 | UGCG (0.75) | UGCGHTR1APTGS1OPRM1 | |
| SCHEMBL763368 | 0.87 | UGCG (0.75) | UGCGHTR1APTGS1OPRM1 | |
| SCHEMBL1088041 | 0.86 | UGCG (0.69) | UGCG | |
| SCHEMBL13057246 | 0.86 | UGCG (0.73) | UGCGHTR1APTGS1OPRM1 | |
| SCHEMBL20653420 | 0.85 | UGCG (0.83) | UGCGHTR1APTGS1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9546161-B2 | Synthesis of UDP-glucose: N-acylsphingosine glucosyl transferase inhibitors | GENZYME CORPORATION (US) | 2017-01-17 | — | — | US | disclosed |
| US-20150148534-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYL TRANSFERASE INHIBITORS | GENZYME CORPORATION | 2015-05-28 | — | — | US | disclosed |
| US-8779163-B2 | Synthesis of UDP-Glucose: N-acylsphingosine glucosyl transferase inhibitors | GENZYME CORPORATION (US) | 2014-07-15 | — | — | US | disclosed |
| US-8288556-B2 | 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity | ALLERGAN, INC. (US) | 2012-10-16 | — | — | US | disclosed |
| US-20120225881-A1 | METHODS OF USING AS ANALGESICS 1-BENZYL-1-HYDROXY-2, 3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYRDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | ALLERGAN, INC. | 2012-09-06 | — | — | US | disclosed |
| US-20120190712-A1 | Methods for Treating Cognitive Disorders | EXONHIT THERAPEUTICS SA (FR) | 2012-07-26 | — | — | US | disclosed |
| US-20120157497-A1 | COMPOUNDS HAVING ANALGESIC AND/OR IMMUNOSTIMULANT ACTIVITY | ALLERGAN, INC. | 2012-06-21 | — | — | US | disclosed |
| US-8173683-B2 | Methods for treating cognitive disorders | ALLERGAN, INC. (US) | 2012-05-08 | — | — | US | disclosed |
| US-8168631-B2 | 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity | ALLERGAN, INC. (US) | 2012-05-01 | — | — | US | disclosed |
| US-8153666-B2 | Compounds having analgesic and/or immunostimulant activity | ALLERGAN, INC. (US) | 2012-04-10 | — | — | US | disclosed |
| US-20100190792-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | ALLERGAN, INC | 2010-07-29 | — | — | US | disclosed |
| US-20100105687-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING 1-ARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 1-HETEROARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS | ALLERGAN, INC. (US) | 2010-04-29 | — | — | US | disclosed |
| US-20100093793-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING 3-ARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES, 3-HETEROARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | ALLERGAN, INC. (US) | 2010-04-15 | — | — | US | disclosed |
| US-20100048642-A1 | METHODS FOR TREATING COGNITIVE DISORDERS | ALLERGAN, INC. (US) | 2010-02-25 | — | — | US | disclosed |
| US-20090318499-A1 | COMPOUNDS HAVING ANALGESIC AND/OR IMMUNOSTIMULANT ACTIVITY | ALLERGAN, INC. | 2009-12-24 | — | — | US | disclosed |
| US-20090281085-A1 | 3-(4-FLUOROPHENYL)-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS HAVING ANALGESIC ACTIVITY | ALLERGAN, INC. | 2009-11-12 | — | — | US | disclosed |
| US-20090088433-A1 | METHODS OF USING AS ANALGESICS 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | ALLERGAN, INC. | 2009-04-02 | — | — | US | disclosed |
| US-20090036436-A1 | 3-ARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES, 3-HETEROARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS HAVING ANALGESIC AND/OR IMMUNO STIMULANT ACTIVITY | ALLERGAN, INC. | 2009-02-05 | — | — | US | disclosed |
| US-20080312236-A1 | 3-Heteroaryl-3-Hydroxy-2-Amino-Propyl Amines And Related Compounds Having Analgesic And/Or Immuno Stimlant Activity | EXONHIT THERAPEUTICS SA (FR) | 2008-12-18 | — | — | US | disclosed |
| US-20070203223-A1 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312236-A1 | 3-Heteroaryl-3-Hydroxy-2-Amino-Propyl Amines And Related Compounds Having Analgesic And/Or Immuno Stimlant Activity | OPRL1, OPRM1, MRGPRX2 | UGCG 2783/4885HTR1A 188/4885PTGS1 85/4885 |
| US-20090088433-A1 | METHODS OF USING AS ANALGESICS 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | OPRL1, OPRK1, AADAT | UGCG 4208/4885HTR1A 81/4885PTGS1 56/4885 |
| US-20090036436-A1 | 3-ARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES, 3-HETEROARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS HAVING ANALGESIC AND/OR IMMUNO STIMULANT ACTIVITY | OPRL1, HCAR2, OPRM1 | UGCG 4112/4885HTR1A 88/4885PTGS1 168/4885 |
| US-20100105687-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING 1-ARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 1-HETEROARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS | SLC1A2, PNMT, HTR2C | UGCG 2434/4885HTR1A 9/4885PTGS1 1381/4885 |
| US-20090281085-A1 | 3-(4-FLUOROPHENYL)-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS HAVING ANALGESIC ACTIVITY | OPRL1, OPRK1, OPRM1 | UGCG 3951/4885HTR1A 271/4885PTGS1 17/4885 |
| US-20090318499-A1 | COMPOUNDS HAVING ANALGESIC AND/OR IMMUNOSTIMULANT ACTIVITY | OPRK1, OPRM1, OPRL1 | UGCG 3478/4885HTR1A 1217/4885PTGS1 64/4885 |
| US-20150148534-A1 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYL TRANSFERASE INHIBITORS | UGCG, UGGT1, DPAGT1 | UGCG 1/4885HTR1A 3523/4885PTGS1 2177/4885 |
| US-20120190712-A1 | Methods for Treating Cognitive Disorders | CHAT, SLC18A3, SLC18A2 | UGCG 556/4885HTR1A 118/4885PTGS1 2164/4885 |
| US-20100190792-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | SLC1A2, SLC1A1, GRIN2A | UGCG 3688/4885HTR1A 27/4885PTGS1 1418/4885 |
| US-20070203223-A1 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | UGCG, UGGT1, DPAGT1 | UGCG 1/4885HTR1A 3504/4885PTGS1 2317/4885 |
| US-20100048642-A1 | METHODS FOR TREATING COGNITIVE DISORDERS | CHAT, SLC18A3, SLC18A2 | UGCG 556/4885HTR1A 118/4885PTGS1 2164/4885 |
| US-20100093793-A1 | METHODS FOR TREATING COGNITIVE DISORDERS USING 3-ARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES, 3-HETEROARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | SLC1A2, AADAT, AANAT | UGCG 2208/4885HTR1A 105/4885PTGS1 2245/4885 |
| US-20120157497-A1 | COMPOUNDS HAVING ANALGESIC AND/OR IMMUNOSTIMULANT ACTIVITY | OPRK1, OPRM1, OPRL1 | UGCG 3478/4885HTR1A 1217/4885PTGS1 64/4885 |
| US-20120225881-A1 | METHODS OF USING AS ANALGESICS 1-BENZYL-1-HYDROXY-2, 3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYRDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS | OPRK1, OPRL1, HRH2 | UGCG 4134/4885HTR1A 104/4885PTGS1 49/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.